Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Brief Summary: The primary purpose of this study is to evaluate the safety for 2 different rivaroxaban treatment strategies and one Vitamin K Antagonist (VKA) treatment strategy utilizing various combinations of dual antiplatelet therapy (DAPT) or low-dose aspirin (ASA) or clopidogrel (or prasugrel or ticagrelor).


Options:
A: Arm Label: Dabigatran Etexilate 110mg; Type: EXPERIMENTAL; Interventions: Drug: Dabigatran Etexilate 110mg, Drug: Clopidogrel or Ticagrelor | Arm Label: Dabigatran Etexilate 150mg; Type: EXPERIMENTAL; Interventions: Drug: Dabigatran Etexilate 150mg, Drug: Clopidogrel or Ticagrelor | Arm Label: Warfarin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Warfarin 3mg, Drug: Aspirin, Drug: Clopidogrel or Ticagrelor, Drug: Warfarin 5mg, Drug: Warfarin 1mg | Intervention Type: DRUG; Name: Dabigatran Etexilate 110mg; Assigned to Arm(s): Dabigatran Etexilate 110mg | Intervention Type: DRUG; Name: Warfarin 3mg; Assigned to Arm(s): Warfarin | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): Warfarin | Intervention Type: DRUG; Name: Dabigatran Etexilate 150mg; Assigned to Arm(s): Dabigatran Etexilate 150mg | Intervention Type: DRUG; Name: Clopidogrel or Ticagrelor; Assigned to Arm(s): Warfarin | Intervention Type: DRUG; Name: Clopidogrel or Ticagrelor; Assigned to Arm(s): Dabigatran Etexilate 110mg | Intervention Type: DRUG; Name: Warfarin 5mg; Assigned to Arm(s): Warfarin | Intervention Type: DRUG; Name: Clopidogrel or Ticagrelor; Assigned to Arm(s): Dabigatran Etexilate 150mg | Intervention Type: DRUG; Name: Warfarin 1mg; Assigned to Arm(s): Warfarin
B: Arm Label: 1. YM150 Dose V, twice daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 2. YM150 Dose W, once daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 3. YM150 Dose X, twice daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 4. YM150 Dose Y, once daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 5. YM150 Dose Y, twice daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 6. YM150 Dose Z, once daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 7. Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: YM150; Assigned to Arm(s): 1. YM150 Dose V, twice daily, 2. YM150 Dose W, once daily, 3. YM150 Dose X, twice daily, 4. YM150 Dose Y, once daily, 5. YM150 Dose Y, twice daily, 6. YM150 Dose Z, once daily | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 7. Placebo
C: Arm Label: Dabigatran 110 mg; Type: EXPERIMENTAL; Interventions: Drug: dabigatran 110 mg | Arm Label: Dabigatran 150 mg; Type: EXPERIMENTAL; Interventions: Drug: dabigatran 150 mg | Arm Label: Unfractionated Heparin; Type: ACTIVE_COMPARATOR; Interventions: Drug: unfractionated heparin | Intervention Type: DRUG; Name: dabigatran 110 mg; Assigned to Arm(s): Dabigatran 110 mg | Intervention Type: DRUG; Name: dabigatran 150 mg; Assigned to Arm(s): Dabigatran 150 mg | Intervention Type: DRUG; Name: unfractionated heparin; Assigned to Arm(s): Unfractionated Heparin
D: Arm Label: rivaroxaban 2.5 mg twice daily; Type: EXPERIMENTAL; Interventions: Drug: rivaroxaban 2.5 mg, Drug: rivaroxaban 15 mg, Drug: rivaroxaban 10 mg, Drug: aspirin (ASA), Drug: clopidogrel, Drug: prasugrel, Drug: ticagrelor | Arm Label: vitamin K antagonist (VKA); Type: EXPERIMENTAL; Interventions: Drug: aspirin (ASA), Drug: vitamin K antagonist (VKA), Drug: clopidogrel, Drug: prasugrel, Drug: ticagrelor | Arm Label: rivaroxaban 15 mg once daily; Type: EXPERIMENTAL; Interventions: Drug: rivaroxaban 15 mg, Drug: rivaroxaban 10 mg, Drug: clopidogrel, Drug: prasugrel, Drug: ticagrelor | Intervention Type: DRUG; Name: rivaroxaban 2.5 mg; Assigned to Arm(s): rivaroxaban 2.5 mg twice daily | Intervention Type: DRUG; Name: rivaroxaban 15 mg; Assigned to Arm(s): rivaroxaban 15 mg once daily, rivaroxaban 2.5 mg twice daily | Intervention Type: DRUG; Name: rivaroxaban 10 mg; Assigned to Arm(s): rivaroxaban 15 mg once daily, rivaroxaban 2.5 mg twice daily | Intervention Type: DRUG; Name: aspirin (ASA); Assigned to Arm(s): rivaroxaban 2.5 mg twice daily, vitamin K antagonist (VKA) | Intervention Type: DRUG; Name: vitamin K antagonist (VKA); Assigned to Arm(s): vitamin K antagonist (VKA) | Intervention Type: DRUG; Name: clopidogrel; Assigned to Arm(s): rivaroxaban 15 mg once daily, rivaroxaban 2.5 mg twice daily, vitamin K antagonist (VKA) | Intervention Type: DRUG; Name: prasugrel; Assigned to Arm(s): rivaroxaban 15 mg once daily, rivaroxaban 2.5 mg twice daily, vitamin K antagonist (VKA) | Intervention Type: DRUG; Name: ticagrelor; Assigned to Arm(s): rivaroxaban 15 mg once daily, rivaroxaban 2.5 mg twice daily, vitamin K antagonist (VKA)

Answer: D